Literature DB >> 2567713

Progesterone administration in patients with absent ovaries.

P Devroey1, G Palermo, C Bourgain, L Van Waesberghe, J Smitz, A C Van Steirteghem.   

Abstract

Forty-four women with absent ovaries who were referred to our centre for oocyte donation were treated with oestradiol valerate and natural progesterone. Serum concentrations and endometrial changes were evaluated on day 21 of stimulated luteal phases after the daily administration of 100 mg of natural progesterone in oil injected intramuscularly or after the ingestion of 300 mg of micronized progesterone or after vaginal administration of 300 mg or 600 mg micronized progesterone, respectively. Endometrial tissue did not show evidence of an adequate secretory pattern after orally administered progesterone. However, after intramuscular injection of 100 mg of natural progesterone and after the vaginal administration of 300 to 600 mg of micronized progesterone, the histologic and electron microscopic pictures were similar in all treatment groups and were close to the expected day 21 of the cycle. Serum levels of progesterone after intramuscular injection were five times higher than after vaginal administration.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567713

Source DB:  PubMed          Journal:  Int J Fertil        ISSN: 0020-725X


  10 in total

Review 1.  Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.

Authors:  Ali Abbara; Sophie A Clarke; Waljit S Dhillo
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

Review 2.  Methods for endometrial preparation in frozen-thawed embryo transfer cycles.

Authors:  Ziya Kalem; Müberra Namlı Kalem; Timur Gürgan
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-09-01

3.  A comparative, randomized study of three different progesterone support of the luteal phase following IVF/ET program.

Authors:  P G Artini; A Volpe; S Angioni; M C Galassi; C Battaglia; A R Genazzani
Journal:  J Endocrinol Invest       Date:  1995-01       Impact factor: 4.256

4.  Assessment of the luteal phase in stimulated and substituted cycles.

Authors:  H M Fatemi
Journal:  Facts Views Vis Obgyn       Date:  2009

5.  A 10-year follow-up on the practice of luteal phase support using worldwide web-based surveys.

Authors:  Gon Shoham; Milton Leong; Ariel Weissman
Journal:  Reprod Biol Endocrinol       Date:  2021-01-26       Impact factor: 5.211

6.  Comparison of Subcutaneous and Vaginal Progesterone Used for Luteal Phase Support in Patients Undergoing Intracytoplasmic Sperm Injection Cycles.

Authors:  Saghar Salehpour; Nasrin Saharkhiz; Leila Nazari; Ali Sobhaneian; Sedighe Hosseini
Journal:  JBRA Assist Reprod       Date:  2021-04-27

7.  Duration of luteal support (DOLS) with progesterone pessaries to improve the success rates in assisted conception: study protocol for a randomized controlled trial.

Authors:  Rafet Gazvani; Richard Russell; Yasmin Sajjad; Zarko Alfirevic
Journal:  Trials       Date:  2012-07-26       Impact factor: 2.279

8.  A multi-center, randomized, open-label, parallel group study of a natural micronized progesterone vaginal tablet as a luteal support agent in Japanese women undergoing assisted reproductive technology.

Authors:  Toshihiro Fujiwara
Journal:  Reprod Med Biol       Date:  2015-06-14

9.  Daytime Variation in Serum Progesterone During the Mid-Luteal Phase in Women Undergoing In Vitro Fertilization Treatment.

Authors:  Lise Haaber Thomsen; Ulrik Schiøler Kesmodel; Claus Yding Andersen; Peter Humaidan
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-19       Impact factor: 5.555

10.  Efficacy of four vaginal progesterones for luteal phase support in frozen-thawed embryo transfer cycles: A randomized clinical trial.

Authors:  Reiko Shiba; Masayuki Kinutani; Shinichiro Okano; Reo Kawano; Yuko Kikkawa
Journal:  Reprod Med Biol       Date:  2019-09-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.